Modulation of VEGF expression in rat bone marrow stromal cells by GDF-5

Connect Tissue Res. 2007;48(6):324-31. doi: 10.1080/03008200701692743.

Abstract

Angiogenesis is essential for bone formation and several bone morphogenetic proteins (BMPs) have been shown to induce angiogenesis through osteoblast-derived vascular endothelial growth factor (VEGF)-A. Growth differentiation factor-5 (GDF-5) is a member of the BMP family expressed in bone and known to induce angiogenesis in vivo. In this study, the effects of GDF-5 on osteogenic differentiation and expression of VEGF-related genes were determined using rat bone marrow stromal cells. GDF-5 stimulated osteogenic differentiation. It also upregulated the expression of VEGF-A after 3 hr, accompanied by a trend of decrease in its receptor VEGFR-2 at 6 and 24 hr. VEGF-D and its receptor VEGFR-3 showed peak expression at later time points. This regulation may be further controlled by neuropilin 2 that exhibited a parallel profile to VEGF-D. These observations indicate that GDF-5 stimulates osteogenic differentiation and has a potential to induce angiogenesis through osteoblast-derived VEGF-A in bone.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow Cells / metabolism*
  • Bone Morphogenetic Proteins / pharmacology*
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Cycloheximide / pharmacology
  • Dactinomycin / pharmacology
  • Growth Differentiation Factor 5
  • Male
  • Osteogenesis / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Stromal Cells / metabolism*
  • Up-Regulation
  • Vascular Endothelial Growth Factor A / biosynthesis*
  • Vascular Endothelial Growth Factor Receptor-2 / biosynthesis

Substances

  • Bone Morphogenetic Proteins
  • Growth Differentiation Factor 5
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, rat
  • Dactinomycin
  • Cycloheximide
  • Vascular Endothelial Growth Factor Receptor-2